Vical receives EMA Scientific Advice for Phase 3 trial of TransVax therapeutic CMV vaccine
Vical receives EMA Scientific Advice for Phase 3 trial of TransVax therapeutic CMV vaccine
Vical Incorporated announced today the receipt of Scientific Advice from the European Medicines Agency (EMA) recommending practical efficacy endpoints for a Phase 3 trial of the company’s TransVax™ therapeutic cytomegalovirus (CMV) vaccine.
Read more on News-Medical-Net
Categories: Breast Cancer Awareness Tags: advice, Phase, receives, Scientific, Therapeutic, TransVax, Trial, vaccine, Vical
Cakes for Cause receives $8K from Frederick Giving Project
Cakes for Cause receives $8K from Frederick Giving Project
Cakes for Cause recently received an $8,000 grant from The Frederick Giving Project Fund, a component fund of The Community Foundation of Frederick County. This grant will be used to support Cakes for Cause apprenticeship program, according to a press release from the Community Foundation.
Read more on Gazette.net
Categories: Breast Cancer Organizations Tags: Cakes, cause, Frederick, From, giving, Project, receives
Hologic Receives FDA Approvable Letter For Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Hologic Receives FDA Approvable Letter For Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that Hologic has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the Selenia Dimensions three-dimensional (3-D …
Read more on Medical News Today
Categories: Breast Cancer Information Tags: Approvable, Digital, Dimensions, Hologic, Letter, mammography, receives, Selenia, system, Tomosynthesis
SPRYCEL receives FDA approval for adult patients with Ph+ CML in chronic phase
SPRYCEL receives FDA approval for adult patients with Ph+ CML in chronic phase
After receiving a priority review, Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved SPRYCEL (dasatinib) 100 mg once daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
Read more on News-Medical-Net
CINJ researcher receives Clinical/Basic Science Research Award
CINJ researcher receives Clinical/Basic Science Research Award
Amar Rewari, MD, MBA, a researcher from The Cancer Institute of New Jersey (CINJ), has been chosen to receive the Clinical Award in Clinical/Basic Science Research at the 52nd Annual Meeting of The American Society for Radiation Oncology (ASTRO) in San Diego next month. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
Read more on News-Medical-Net
Categories: Breast Cancer Doctors Tags: Award, CINJ, Clinical/Basic, receives, research, Researcher, science